Search Results - david+stevenson

3 Results Sort By:
Polymeric Delivery Platform for Therapeutics
Abstract: Drug delivery technologies have long claimed the ability to selectively deliver therapeutic cargo to target cells. Despite advances in nanomedicine and drug delivery systems, there are no targeted nanoscale drug delivery technologies on the market. Thus, there is still tremendous potential in improved therapeutic efficacy when targeted drug...
Published: 4/22/2025   |   Updated: 8/2/2023   |   Inventor(s): David Stevens, Stephan Stern, Scott McNeil, Marina Dobrovolskaia
Keywords(s): Drug Delivery, Immunotherapy, Scavenger Receptor A1, SR-A1
Category(s): Application > Therapeutics, TherapeuticArea > Infectious Disease, TherapeuticArea > Immunology, TherapeuticArea > Neurology, Collaboration Sought > Collaboration, Collaboration Sought > Licensing, TherapeuticArea > Oncology
Size-dependent brain distribution of macromolecular drug delivery platform
Summary: The NCI seeks research co-development partners and/or licensees for a selective polylysine succinylated (PLS) drug delivery platform. Description of Technology: The blood brain barrier (BBB) is a specialized endothelium that prevents the uptake of substances from the systemic circulation into the central nervous system. This barrier, while...
Published: 4/24/2026   |   Updated: 8/2/2023   |   Inventor(s): Stephan Stern, David Stevens
Keywords(s): BBB, Blood-brain Barrier, Brain Cancer, Controlled Drug Release, Drug Delivery Platform, Neurological Disorders, Stern
Category(s): TherapeuticArea > Oncology, Collaboration Sought > Collaboration, Collaboration Sought > Licensing, TherapeuticArea > Neurology
PREDICTION OF PREECLAMPSIA RISK USING CIRCULATING CELL-FREE RNA
PREDICTION OF PREECLAMPSIA RISK USING CIRCULATING CELL-FREE RNA Researchers at Stanford and the Chan Zuckerberg Biohub have developed methods for predicting the risk or existence of preeclampsia. Preeclampsia, a multi-organ syndrome diagnosed after 20 weeks of gestation, is associated with an increase in adverse maternal and perinatal outcomes. Detection...
Published: 10/14/2024   |   Updated: 6/24/2021   |   Inventor(s): Stephen Quake, Gary Shaw, David Stevenson, Mira Moufarrej
Keywords(s): cfRNA, Diagnosis, Gestational Age, Machine Learning, Maternal Blood, Maternal Plasma
Category(s): Technology Classifications > Biology